Aricept tablet 5 mg (donepezil hcl) — same day delivery. Donepezil hydrochloride is used for the palliative treatment of mild to moderate dementia of the Alzheimer's type Alzheimer's disease, ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Donepezil increases the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil alters the course of the underlying ...

Drug firm Unichem Laboratories has received approval from the US health regulator for it's Donepezil Hydrochloride tablets used for improving cognition and behaviour of people suffering with Alzheimer ...

Donepezil (Alzil) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving mental ...

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...

Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...

BRIDGEWATER, N.J., January 23, 2025--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has ...

Ranbaxy Laboratories’ Canadian subsidiary Ranbaxy Pharmaceuticals Canada Inc has received approval to manufacture and sell Donepezil Hydrochloride 5 mg and 10 mg. The drug is used to treat dementia in ...

Ranbaxy Laboratories Ltd has submitted to BSE a copy of Press Release dated January 08, 2014 titled "Ranbaxy receives approval to market RANTM Donepezil in Canada" Ranbaxy Pharmaceuticals Canada Inc. ...

WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)-- Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...